Navigation Links
Heart Hospital of Austin First in World to Use New Device for Blocked Arteries
Date:1/8/2009

New magnetically-navigated guidewire provides minimally-invasive treatment for Peripheral Artery Disease

AUSTIN, Texas, Jan. 8 /PRNewswire/ -- The Heart Hospital of Austin is the first hospital in the world to use the new Stereotaxis RF PowerAssert(TM) Magnetic Guidewire to successfully treat chronic total occlusions (CTOs), or complete blockages in patients with peripheral artery disease.

Austin Heart interventional cardiologist, Frank Zidar, M.D. used the new device on Wednesday, January 7, 2009, on a patient with severe peripheral artery disease (PAD). The patient had 100% blockage in a main artery in his leg. Without proper treatment, he would continue to experience chronic, severe pain in his leg due to poor circulation, according to a hospital spokesperson.

"Traditional treatment for blocked arteries uses manual guidewires to travel through the artery to the area of blockage in the leg. This can be extremely challenging because these guidewires are very difficult to maneuver. This new magnetic guidewire technology allows for greater control and improved accuracy," explains Dr. Frank Zidar.

"Once the blockage is reached, the tip of the guidewire can burn or ablate a tiny passage through the blockage, allowing us then to use existing techniques to open up the blockage further. This revolutionary technology will likely reduce procedure times and therefore reduce the amount of contrast dye and imaging radiation to the patient," he added.

Peripheral Artery Disease affects eight to twelve million Americans, according to the American Heart Association. If left untreated, patients can experience ulcerations and gangrene that significantly increase their risk of losing a limb or even result in death.

The Stereotaxis RF PowerAssert(TM) Magnetic Guidewire was approved by the FDA in August 2008. It is the only magnetically enabled device capable of intra-lesion steering available for crossing completely blocked arteries.

Heart Hospital of Austin was chosen as one of only two clinical sites in the world to study the efficacy of the new Stereotaxis RF PowerAssert(TM) Magnetic Guidewire.


'/>"/>
SOURCE Heart Hospital of Austin
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD
2. Mortality rates higher for heart disease patients in poorer B.C. neighborhoods
3. CVBT Opens Two Additional Sites for Its ACORD Phase II Heart Trial
4. Heart Drug May Be a Cancer Fighter
5. Traditional risk assessment tools do not accurately predict coronary heart disease
6. New SMHEART LINK(TM) Technology Allows iPhones to Double as Fitness Monitors
7. Randy Jackson and the American Heart Association Encourage Philadelphia Residents to Get In The K.N.O.W. About Improving Type 2 Diabetes Management
8. New appropriate use criteria guide treatment of patients with heart blockage
9. Viagra May Shield Heart From Blood Pressure Damage
10. New hope for cancer comes straight from the heart
11. When the Heart Stops Beating
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... a legally blind and certified personal trainer is helping to develop a weight loss fitness ... to fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
Breaking Medicine Technology: